Dyne Therapeutics stock reached a 52-week low of $17.54 USD, marking a significant point in its recent trading performance.
A 52-week low indicates a significant downturn in a stock's performance over the past year, potentially signaling investor concerns or market pressures affecting the company.
Dyne Therapeutics' stock has hit a new 52-week low, trading at $17.54 USD. This development reflects the recent performance of the company's shares in the market.
Pick the topics you care about. Get only what matters, on your cadence.